eureKARE

🏷️ vc
Visit Website ↗
Investment Thesis

Eure KARE invests in Europe, the UK, and Israel to unlock the potential of synthetic biology and microbiome research. The firm believes these fields can address critical global challenges—from healthcare innovations like cell therapies and gene therapies to environmental solutions such as biofuels and pollution control—by commercializing Europe’s strong scientific research base and creating new industries.

Stage Focus
Early Stage

Preferred startup development maturity for initial funding deployment.

Sectors & Themes

Cutting-edge synthetic biology and microbiome technologies with applications in healthcare, agriculture, energy, and environmental sustainability.

Core thematic spaces, technologies, and target market segments of interest.

Check Size Range
N/A

Standard financial allocation per investment round.

Outreach & Dossier Intelligence

Direct Verification Contact Email Pattern

[email protected] | [email protected]

Thesis Dossier Analysis Scorecard

Our agent analyzer scanned portfolio holdings and verified absolute match parameters...

Unlock Verified Partner Contacts

Find verified email templates, direct outreach copy created by AI, and calculate exact thesis match scores with 1-click.

Create Free Account to Unlock

Takes less than 30 seconds · No card required